President Donald Trump has signed an executive order that he claims will cut prescription drug prices supplied to the US to ...

A digital therapy that could reduce the severity chronic tic disorders like Tourette syndrome has been recommended for use by ...

Tom Keith-Roach, president of AZ's UK business, said: "The UK approval of Trixeo Aerosphere with the [new] propellant marks a ...

"We can use…AI to estimate a person's biological age from face pictures, and our study shows that information can be ...

A larger waist circumference is associated with a higher risk of all-cause mortality and decreased life expectancy. Meanwhile ...

President Donald Trump has said he will sign an executive order today that will cut prescription drug prices supplied to ...

Pfizer has partnered with a ‘computation-driven’ pharmaceutical technology company to develop a drug discovery platform powered by artificial intelligence (AI). Its collaboration with ...

Sanofi and Regeneron's Dupixent (dupilumab) has been approved by the FDA for the treatment of chronic spontaneous urticaria (CSU), a condition that causes painful hives that often don't respond to ...

This pre-recorded webinar was fully funded by Chiesi GRD and hosted by pharmaphorum. Professor Maurizio Scarpa received an honorarium for his participation and contribution to this webinar.

Swiss start-up Granite Bio has carved out $100 million in a pair of financings for its pipeline of potentially first-in-class antibodies for autoimmune diseases. The Basel-based company has one ...

Threshold Pharma is to go ahead with Phase 3 clinical trials of its only drug, TH-302, despite recent Phase 2 trials failing to show statistically significant improvement in overall survival.